[Form 4] LeMaitre Vascular, Inc. Insider Trading Activity
LeMaitre Vascular insider sale disclosed on Form 4. Director Lawrence J. Jasinski sold 976 shares of Common Stock on 08/12/2025 at $92.78 per share, and after the transaction beneficially owned 4,773 shares directly. The filing lists the issuer as LeMaitre Vascular, Inc. (LMAT) and indicates the Form 4 was filed as an individual report. The document contains no options or other derivative transactions.
Comunicato di vendita interna di LeMaitre Vascular riportato nel Modulo 4. Il direttore Lawrence J. Jasinski ha venduto 976 azioni di azioni ordinarie il 12/08/2025 a 92,78 USD per azione; dopo l'operazione deteneva direttamente 4.773 azioni. Il file indica l'emittente come LeMaitre Vascular, Inc. (LMAT) e specifica che il Modulo 4 猫 stato presentato a titolo individuale. Il documento non riporta opzioni n茅 altre transazioni su derivati.
Venta interna de LeMaitre Vascular divulgada en el Formulario 4. El director Lawrence J. Jasinski vendi贸 976 acciones ordinarias el 12/08/2025 a 92,78 USD por acci贸n; tras la transacci贸n pose铆a directamente 4.773 acciones. La presentaci贸n identifica al emisor como LeMaitre Vascular, Inc. (LMAT) e indica que el Formulario 4 se present贸 como informe individual. El documento no contiene opciones ni otras operaciones con derivados.
LeMaitre Vascular 雮措秬鞛� 毵る弰, Form 4鞐� 瓿奠嫓. 鞚挫偓 Lawrence J. Jasinski電� 2025-08-12鞐� 氤错喌欤� 976欤茧ゼ 欤茧嫻 92.78雼煬鞐� 毵る弰頄堨溂氅�, 瓯半灅 頉� 歆侅爲 氤挫湢頃� 欤检嫕鞚� 4,773欤检榾鞀惦媹雼�. 鞝滌稖靹滊電� 氚滍枆須岇偓毳� LeMaitre Vascular, Inc. (LMAT)搿� 旮办灛頃橁碃 Form 4臧� 臧滌澑 氤搓碃靹滊 鞝滌稖霅橃棃鞚岇潉 氇呾嫓頃╇媹雼�. 氍胳劀鞐愲姅 鞓奠厴鞚措倶 旮绊儉 韺岇儩靸來拡 瓯半灅電� 鞐嗢姷雼堧嫟.
Vente d'initi茅 de LeMaitre Vascular divulgu茅e dans le Formulaire 4. Le administrateur Lawrence J. Jasinski a vendu 976 actions ordinaires le 12/08/2025 au prix de 92,78 USD par action ; apr猫s la transaction, il d茅tenait directement 4 773 actions. le dossier indique l'茅metteur comme LeMaitre Vascular, Inc. (LMAT) et pr茅cise que le Formulaire 4 a 茅t茅 d茅pos茅 en tant que d茅claration individuelle. Le document ne contient ni options ni autres transactions sur d茅riv茅s.
Insider-Verkauf von LeMaitre Vascular im Formular 4 offengelegt. Direktor Lawrence J. Jasinski verkaufte am 12.08.2025 976 Stammaktien zu je 92,78 USD; nach der Transaktion hielt er direkt 4.773 Aktien. Die Einreichung nennt den Emittenten LeMaitre Vascular, Inc. (LMAT) und gibt an, dass das Formular 4 als individuelle Meldung eingereicht wurde. Das Dokument enth盲lt keine Optionen oder sonstige Derivategesch盲fte.
- None.
- Director Lawrence J. Jasinski reported a sale of 976 shares of LeMaitre Vascular common stock on 08/12/2025 at $92.78 per share.
Insights
TL;DR: A routine insider sale by a director; limited standalone market implication without further context.
The Form 4 shows a single non-derivative transaction: 976 shares sold at $92.78 on 08/12/2025, leaving the director with 4,773 shares. As presented, this is a straightforward disclosure of a sale by a director and does not include accompanying derivative activity or an indication of a Rule 10b5-1 plan. Without additional filings or context about the director's historical trading patterns or the size of the holding relative to total outstanding shares, the sale should be treated as an informational corporate insider activity rather than definitive evidence of company-wide developments.
TL;DR: Compliance filing meeting Section 16 disclosure requirements; no governance red flags visible in this record.
The disclosure identifies the reporting person as a director and records a direct sale of common stock. The Form 4 entries are complete for non-derivative holdings and show no indirect beneficial ownership or additional transactions. The presence of a signature block and filing dates indicates procedural compliance. There is no evidence in this filing of unusual trading patterns, pledging, or derivative use that would raise immediate governance concerns.
Comunicato di vendita interna di LeMaitre Vascular riportato nel Modulo 4. Il direttore Lawrence J. Jasinski ha venduto 976 azioni di azioni ordinarie il 12/08/2025 a 92,78 USD per azione; dopo l'operazione deteneva direttamente 4.773 azioni. Il file indica l'emittente come LeMaitre Vascular, Inc. (LMAT) e specifica che il Modulo 4 猫 stato presentato a titolo individuale. Il documento non riporta opzioni n茅 altre transazioni su derivati.
Venta interna de LeMaitre Vascular divulgada en el Formulario 4. El director Lawrence J. Jasinski vendi贸 976 acciones ordinarias el 12/08/2025 a 92,78 USD por acci贸n; tras la transacci贸n pose铆a directamente 4.773 acciones. La presentaci贸n identifica al emisor como LeMaitre Vascular, Inc. (LMAT) e indica que el Formulario 4 se present贸 como informe individual. El documento no contiene opciones ni otras operaciones con derivados.
LeMaitre Vascular 雮措秬鞛� 毵る弰, Form 4鞐� 瓿奠嫓. 鞚挫偓 Lawrence J. Jasinski電� 2025-08-12鞐� 氤错喌欤� 976欤茧ゼ 欤茧嫻 92.78雼煬鞐� 毵る弰頄堨溂氅�, 瓯半灅 頉� 歆侅爲 氤挫湢頃� 欤检嫕鞚� 4,773欤检榾鞀惦媹雼�. 鞝滌稖靹滊電� 氚滍枆須岇偓毳� LeMaitre Vascular, Inc. (LMAT)搿� 旮办灛頃橁碃 Form 4臧� 臧滌澑 氤搓碃靹滊 鞝滌稖霅橃棃鞚岇潉 氇呾嫓頃╇媹雼�. 氍胳劀鞐愲姅 鞓奠厴鞚措倶 旮绊儉 韺岇儩靸來拡 瓯半灅電� 鞐嗢姷雼堧嫟.
Vente d'initi茅 de LeMaitre Vascular divulgu茅e dans le Formulaire 4. Le administrateur Lawrence J. Jasinski a vendu 976 actions ordinaires le 12/08/2025 au prix de 92,78 USD par action ; apr猫s la transaction, il d茅tenait directement 4 773 actions. le dossier indique l'茅metteur comme LeMaitre Vascular, Inc. (LMAT) et pr茅cise que le Formulaire 4 a 茅t茅 d茅pos茅 en tant que d茅claration individuelle. Le document ne contient ni options ni autres transactions sur d茅riv茅s.
Insider-Verkauf von LeMaitre Vascular im Formular 4 offengelegt. Direktor Lawrence J. Jasinski verkaufte am 12.08.2025 976 Stammaktien zu je 92,78 USD; nach der Transaktion hielt er direkt 4.773 Aktien. Die Einreichung nennt den Emittenten LeMaitre Vascular, Inc. (LMAT) und gibt an, dass das Formular 4 als individuelle Meldung eingereicht wurde. Das Dokument enth盲lt keine Optionen oder sonstige Derivategesch盲fte.
FAQ
What did the Form 4 filed for LMAT disclose?
What is the reporting person's relationship to LMAT?
Were any derivative securities reported in this Form 4 for LMAT?
How many shares does the director own after the reported transaction?
When was the transaction executed and when was the Form 4 filed?
